Director, Regional Site Liaison

About Jade Biosciences

Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn .

Role Overview

Reporting to the E xecutive D irector of Clinical Partnerships & Engagement, the Regional Site L iaison ( RS L) is a field-based operational and scientific partner who serves as a critical link between Jade and clinical trial sites. This role is responsible for local clinical leadership and accountability, and will driv e site engagement, ensure consistency in trial execution, and leverage regional insights to ensure successful clinical trial enrollment.

Key Responsibilities

• Build and maintain strong relationships with Principal Investigators (PIs), site staff and KOLs in support of planned and active clinical trials.

• Organize and execute in-person visits with PIs and site teams.

• Serve as the Jade primary point of contact for regionally assigned clinical trial sites across one or more programs:

<li data-leveltext="o" data-font="Courier New" data-listid="39" data-list-defn-props="{"335552541":1,"335559685":1440,"335559991":360,"469769226":&quo